Invention Grant
US09062108B2 Dual specific binding proteins directed against IL-1 and/or IL-17
有权
针对IL-1和/或IL-17的双重特异性结合蛋白
- Patent Title: Dual specific binding proteins directed against IL-1 and/or IL-17
- Patent Title (中): 针对IL-1和/或IL-17的双重特异性结合蛋白
-
Application No.: US14211604Application Date: 2014-03-14
-
Publication No.: US09062108B2Publication Date: 2015-06-23
- Inventor: Tariq Ghayur , JiJie Gu , Maria Harris , Carrie Goodreau , Sonal Saluja
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/40 ; C07K16/24 ; A61K47/48 ; A61K45/06 ; G01N33/68 ; C07K16/00
Abstract:
Engineered multivalent and multispecific binding proteins that bind IL-1β and/or IL-17 are provided, along with methods of making and uses in the prevention, diagnosis, and/or treatment of disease.
Public/Granted literature
- US20140271458A1 DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1 and/or IL-17 Public/Granted day:2014-09-18
Information query
